The novel approach of this peptide represents a major advance in the care of the condition. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – providing https://tirzepatidepeptide690738.educationalimpactblog.com/63597910/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment